Corneal Thinning During Topical Bevacizumab Therapy

Sponsor
Yonsei University
Study ID
NCT00515684
Status
Withdrawn

Conditions

  • Corneal Neovascularization

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

The purpose of this study is to determine whether topical bevacizumab is safe or not when used in corneal neovascularization for long term period.

Key Dates

First listed
Aug 14, 2007
Start date
May 31, 2007
Status verified
Apr 2015
Primary completion
Dec 31, 2008
Completion
Dec 31, 2008

Study Design

Enrollment
0 participants (actual)
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE

Related Studies